Navigation Links
T. Denny Sanford donates $50 million to Burnham Institute for Medical Research
Date:1/26/2010

LA JOLLA, Calif., January 26, 2010 Burnham Institute for Medical Research (Burnham) announced today that philanthropist T. Denny Sanford has pledged $50 million to support and further expand and accelerate the Institute's leading-edge medical research. To honor Sanford, Burnham, has been renamed the Sanford-Burnham Medical Research Institute. This is the second gift Sanford has made to Burnham. In 2007, he directed $20 million through Sanford Health to create the Sanford Children's Health Research Center at Burnham.

"Denny Sanford's continuing generosity will help us make a greater impact on human health," said John C. Reed, M.D., Ph.D., President and CEO, professor and Donald Bren Presidential Chair. "Medical research is changing rapidly. This gift provides a base that enhances our ability to innovate, allowing us to create and maintain technological capabilities that empower great science and also providing seed funding for new ideas that generate promising pilot results so critical for competitive grant applications. At the other end of the spectrum, this remarkable gift provides much-needed support for translating our discoveries into novel strategies for prevention, diagnosis and therapy of diseases."

The Sanford gift will significantly strengthen Burnham's endowment. While Burnham has been extremely successful at winning grant support from the National Institutes of Health (NIH), achieving eight consecutive years of double-digit growth in grant revenue and currently ranking fourth in the nation among similar organizations, philanthropy provides funding for initiatives not typically supported by the NIH and ensures stability in an increasingly competitive grant environment. The gift will be made in $10 million increments for five years.

"Since the Sanford Children's Health Research Center was established, I have had the opportunity to observe the incredible research being conducted by Burnham scientists," said Denny Sanford. "With this gift I have challenged others to join me in supporting this life-changing science."

Malin Burnham, whose own gift catalyzed a similar transformation in 1996, welcomes the change and the challenge. "We are all honored by the confidence Denny Sanford has shown in the Institute," said Burnham. "These additional resources will help our scientists address many of the world's most devastating diseases faster, and that will benefit patients."

In less than two and a half years, Denny Sanford has invested $100 million in San Diego life-science organizations. Sanford has given Burnham, both individually and through Sanford Health, $70 million. In 2008, Sanford donated $30 million to the San Diego Consortium for Regenerative Medicine, now known as the Sanford Consortium for Regenerative Medicine, to construct its state-of-the-art stem cell research facility. Burnham is a member of the Consortium.

"This gift will bring long-term benefits to our bicoastal Institute operating in California and Florida, our many collaborators, and millions suffering from disease," said Greg Lucier, Chairman of the Burnham Board of Trustees and CEO of Life Technologies Corporation.

"California is home to the world's finest biotechnology businesses and institutions that are not only producing a healthier tomorrow but also providing hundreds of thousands of jobs and generating tens of billions of dollars in economic impact in our state today," said California Governor Arnold Schwarzenegger. "I applaud Denny Sanford for his generous donations to this industry and to the Burnham Institute's cutting-edge research. Discoveries being made by our biomedical research community have already given millions help and hope, and I look forward to the life-enhancing results and new jobs created by this partnership."


'/>"/>

Contact: Josh Baxt
jbaxt@burnham.org
858-795-5236
Sanford-Burnham Medical Research Institute
Source:Eurekalert

Related biology news :

1. Carnegie donates landmark clones to biology
2. Structure of 450 million year old protein reveals evolutions steps
3. First orchid fossil puts showy blooms at some 80 million years old
4. SyntheMed Completes $2.8 Million Equity Financing
5. Rutgers Genetics receives $7.8 million for autism research
6. Seattle Childrens Hospital leads $23.7 million NIH grant to study gene repair
7. UD leads $5.3-million research project on rice epigenetics
8. Rutgers high school outreach gets $3 million boost from NSF
9. NIH awards researcher $1.5 million new innovator grant for fruit-fly studies of prion proteins
10. UD leads $5.3-million research project on rice epigenetics
11. $22 million gift from Alfred Taubman launches new biomedical research institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/21/2016)... , June 21, 2016 NuData ... the new role of principal product architect and ... the director of customer development. Both will report ... technical officer. The moves reflect NuData,s strategic growth ... response to high customer demand and customer focus ...
(Date:6/15/2016)... New York , June 15, 2016 /PRNewswire/ ... a new market report titled "Gesture Recognition Market by ... and Forecast, 2016 - 2024". According to the report, ... USD 11.60 billion in 2015 and is estimated ... reach USD 48.56 billion by 2024.  ...
(Date:6/7/2016)... TORONTO , June 7, 2016  Syngrafii ... begun a business relationship that includes integrating Syngrafii,s ... pilot branch project. This collaboration will result in ... for the credit union, while maintaining existing document ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... on quality, regulatory and technical consulting, provides a free webinar on ... on July 13, 2016 at 12pm CT at no charge. , Incomplete investigations ...
Breaking Biology Technology: